These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11144544)

  • 1. National surveillance: a Canadian perspective.
    Njoo H
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S139-45. PubMed ID: 11144544
    [No Abstract]   [Full Text] [Related]  

  • 2. Case definitions for diseases under national surveillance.
    Can Commun Dis Rep; 2000 May; 26 Suppl 3():i-iv 1-122. PubMed ID: 11055080
    [No Abstract]   [Full Text] [Related]  

  • 3. Canadian Communicable Disease Surveillance System. Disease-specific case definitions and surveillance methods.
    Can Dis Wkly Rep; 1991; 17 Suppl 3():1-35. PubMed ID: 2065369
    [No Abstract]   [Full Text] [Related]  

  • 4. [Organization of tuberculosis control in France in 2011].
    Antoun F
    Rev Prat; 2012 Apr; 62(4):507-9. PubMed ID: 22641892
    [No Abstract]   [Full Text] [Related]  

  • 5. Canadian guidelines for the investigation and follow-up of individuals under medical surveillance for tuberculosis after arrival in Canada.
    ;
    Can Commun Dis Rep; 2001 Oct; 27(19):157-65. PubMed ID: 11605359
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemiological surveillance and its prospects in the region.
    Wahdan MH
    East Mediterr Health J; 1999 Sep; 5(5):878-9. PubMed ID: 10983525
    [No Abstract]   [Full Text] [Related]  

  • 7. [Institute of Health Surveillance: from data collection to health alerts. Interview by Corinne Taeron].
    Brücker G
    Rev Infirm; 2003 Jan; (87):25-6. PubMed ID: 12677900
    [No Abstract]   [Full Text] [Related]  

  • 8. A critical review of the infectious diseases surveillance system in the Gaza Strip.
    Awad R; Al Rahman Omer A; Abu Shahla N
    East Mediterr Health J; 2001; 7(1-2):274-9. PubMed ID: 12596978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surveillance system based on infectious diseases law].
    Nomura T
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():394-401. PubMed ID: 12718002
    [No Abstract]   [Full Text] [Related]  

  • 10. [Infectious disease surveillance in France: objectives and organization].
    Joly C; Botherel AH
    Rev Infirm; 2003 Jan; (87):21-3. PubMed ID: 12677899
    [No Abstract]   [Full Text] [Related]  

  • 11. Setting priorities: the Canadian experience in communicable disease surveillance.
    Carter AO;
    MMWR Morb Mortal Wkly Rep; 1992 Dec; 41 Suppl():79-84. PubMed ID: 1344268
    [No Abstract]   [Full Text] [Related]  

  • 12. A summary of the 1996-1997 Canadian FluWatch program.
    Litt M; Buck P; Hockin J; Sockett P
    Can Commun Dis Rep; 1998 Jan; 24(2):11-15. PubMed ID: 9553279
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines for the investigation of individuals who were place under surveillance for tuberculosis post-landing in Canada. Canadian Thoracic Society, the Tuberculosis Directors of Canada and the Department of National Health and Welfare.
    CMAJ; 1993 Jun; 148(11):1957-60. PubMed ID: 8500032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for the investigation and follow-up of individuals under medical surveillance for tuberculosis after arriving in Canada: a summary.
    Heywood N; Kawa B; Long R; Njoo H; Panaro L; Wobeser W;
    CMAJ; 2003 Jun; 168(12):1563-5. PubMed ID: 12796337
    [No Abstract]   [Full Text] [Related]  

  • 15. Invited commentary: real-time tracking of control measures for emerging infections.
    Lipsitch M; Bergstrom CT
    Am J Epidemiol; 2004 Sep; 160(6):517-9; discussion 520. PubMed ID: 15353410
    [No Abstract]   [Full Text] [Related]  

  • 16. Adopting control principles in a novel setting.
    Wahlström H; Englund L
    Vet Microbiol; 2006 Feb; 112(2-4):265-71. PubMed ID: 16325356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The surveillance system of communicable diseases based on the Communicable Diseases law and the utilization of the data collected].
    Shobayashi T
    Nihon Rinsho; 2007 Mar; 65 Suppl 3():13-22. PubMed ID: 17491359
    [No Abstract]   [Full Text] [Related]  

  • 18. TB across the globe (4). The United Kingdom experience.
    Watson J
    Scott Med J; 2000 Oct; 45(5 Suppl):16-7. PubMed ID: 11130306
    [No Abstract]   [Full Text] [Related]  

  • 19. The priorities for antiviral drug resistance surveillance and research.
    Pillay D
    J Antimicrob Chemother; 2007 Aug; 60 Suppl 1():i57-8. PubMed ID: 17656384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response from IUATLD.
    Enarson DA; el Sony A; Bam DS
    Scott Med J; 2000 Oct; 45(5 Suppl):60-2. PubMed ID: 11130321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.